Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 LEI · 988400ZL885PLZG8E576 KO Manufacturing
Open in API
Filings indexed 561 across all filing types
Latest filing 2026-06-18 Investor Presentation
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 95% confidence The document announces the scheduling and details of an upcoming investor presentation (IR event) including date, time, location, participants, purpose, and materials posting date and site. It includes terms like '기업설명회(IR)' which means investor presentation and serves to enhance understanding of the company's business and value. There are no actual financial results or detailed analysis in the text, only information about the event itself. Therefore, it matches the 'Investor Presentation (IP)' category rather than a report or announcement of report publication.
2026-06-18 Korean
기업설명회(IR)개최
Investor Presentation Classification · 95% confidence The document is an announcement of an upcoming Investor Relations (IR) event, specifically a corporate presentation or investor meeting scheduled for June 16-17, 2026. It includes details such as date, time, location, target attendees, purpose, method (Non-Deal Roadshow), content (business explanation and Q&A), and contact information. No actual financial data, report content, or detailed analysis is provided. Given that it is an announcement of an event intended for investors that includes presentation materials but is not itself the presentation or full report, this fits the description of an Investor Presentation (IP) filing category.
2026-06-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 95% confidence The document is titled "주식등의 대량보유상황보고서" (Report of Large Shareholdings) and details extensive information on share ownership, percentage holdings, changes, related parties, and specific threshold movements. This aligns exactly with a Major Shareholding Notification filing under Korean capital markets regulations. There is no discussion of financial statements, management updates, or other report types.
2026-06-09 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 45% confidence The document is a notice announcing the scheduling and details of an upcoming investor relations roadshow (기업설명회 IR). It does not contain actual financial data or presentation content itself, nor is it a formal financial report. It represents a regulatory announcement of an IR event, which falls under the general catch-all Regulatory Filings category (RNS).
2026-06-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 85% confidence The document is a Korean regulatory “주식등의 대량보유상황보고서(약식)” detailing a large shareholding situation by Samsung Asset Management, including holdings, percentages, and transaction history under the Capital Markets Act. This is a direct notification of significant share ownership changes crossing reporting thresholds. Hence it is classified as a Major Shareholding Notification.
2026-05-29 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 86% confidence The document is a brief notice announcing the scheduling and details of a corporate investor relations roadshow (IR meeting). It does not contain actual financial statements or an investor slide deck, nor does it constitute an Annual or Interim Report, Earnings Release, or other specific filing type. It is an exchange announcement of an event, which falls under general regulatory announcements. Therefore, it is classified as a Regulatory Filing (RNS).
2026-05-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.